^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Genomtec

    i
    Other names: Genomtec
    Evidence

    News

    2years
    Genomtec receives $5.5M to develop cancer mutation detection technology (Genomeweb)
    "Polish molecular diagnostic company Genomtec announced...that it has received PLN 21.6 million ($5.5 million) from the Polish Agency for Enterprise Development (PARP) to develop technology to detect cancer mutations... solutions and isothermal nucleic acid amplification techniques, it said in a statement, adding that laboratory work will be conducted on the mutation detection technology using microfluidic cards and further developed using a dedicated analyzer."
    Financing